WSJ.com: Health

Health
  1. Doubt Cast on Potential Alzheimer's Treatment
    Four research teams have been unable to replicate a finding of a 2012 study that showed how an existing cancer drug reversed signs of Alzheimer's disease in the brains of mice.
  2. Two States Seek Help to Start Health Exchanges
    Two states that had planned to run health-insurance exchanges this fall are asking the federal government for help, a sign of the obstacles states face in carrying out a centerpiece of the health-care overhaul.
  3. Cancer Drugs' New Weapon
    Two early-stage studies provided evidence that harnessing the immune system is emerging as a weapon against cancer.
  4. FDA Panel Backs Merck Insomnia Drug
    A federal advisory panel on Wednesday partly endorsed a proposed sleep drug from Merck, saying the product was effective and acceptably safe at lower starting doses.
  5. Can You Catch Up on Lost Sleep?
    Will sleeping more on the weekend make up for lost snoozing during the work week?
  6. Electronic Health Data Gaining Favor, HHS Says
    More than half of U.S. doctors have switched to electronic health records and are using them to manage patients' basic medical information and prescriptions.
  7. Pfizer to Spin Off Remaining Zoetis Stake
    Pfizer plans to shed its majority stake in animal-health company Zoetis, continuing Pfizer's efforts to its hone its focus on drugs and vaccines for humans.
  8. A Dilemma in the Breast-Cancer Hunt
    Doctors are divided about how best to scan "dense" breasts. A look at the options.
  9. New Tracking of a Patient's Radiation Exposure
    Some hospital groups are measuring patients' cumulative medical radiation exposure from tests and scans. This move may shape treatment decisions for patients and their doctors.
  10. Michigan Hospitals Call Off Merger Talks
    Beaumont Health System and Henry Ford Health System, two of Michigan's largest hospital systems, called off plans to merge.
  11. Cardio vs. Weights: A Running Argument
    A wife and husband differ about the best way to stay in shape. And the winner is…
  12. Blurry Line on Marijuana-DUI Cases
    As some states relax laws on pot possession, lawmakers are struggling to create rules for how police officers should identify motorists who are driving under the influence of marijuana.
  13. FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns
    FDA staff said a proposed sleep drug from Merck was effective, but questioned the safety of the product's higher doses. Merck is seeking FDA approval of a drug called suvorexant to treat insomnia. The product will be reviewed Wednesday by an FDA advisory committee.
  14. When Social Skills Are a Warning
    Behavior changes can signal mental-health issues early, recent research indicates. Recognizing social changes could allow for earlier treatment.
  15. Actavis to Buy Warner Chilcott in $5 Billion Deal
    Actavis agreed to acquire Warner Chilcott for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specialty pharmaceutical brands and shrinking its tax burden.

Additional information